Propofol infusion syndrome in adults: A clinical update

Critical Care Research and Practice

Volumn 2015, Issue , 2015, Pages

  Mirrakhimov, Aibek E ^a   Voore, Prakruthi ^a   Halytskyy, Oleksandr ^a   Khan, Maliha ^a   Ali, Alaa M ^a  

^a SAINT JOSEPH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928975178     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2015/260385     Document Type: Review

References (71)

1. M. C. Reade and S. Finfer, "Sedation and delirium in the intensive care unit, " The New England Journal of Medicine, vol. 370, no. 5, pp. 444-454, 2014.
2. Y. Kotani, M. Shimazawa, S. Yoshimura, T. Iwama, andH. Hara, "The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties, " CNS Neuroscience and Therapeutics, vol. 14, no. 2, pp. 95-106, 2008.
3. "Adverse effects of propofol (Diprivan), " Ugeskrift for Laeger, vol. 152, no. 16, p. 1176, 1990.
4. T. J. Parke, J. E. Stevens, A. S. C. Rice et al. , "Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports, " BritishMedical Journal, vol. 305, no. 6854, pp. 613-616, 1992.
5. R. J. Bray, "Propofol infusion syndrome in children, " Paediatric Anaesthesia, vol. 8, no. 6, pp. 491-499, 1998.
6. M. A. Marinella, "Lactic acidosis associated with propofol, " Chest, vol. 109, no. 1, p. 292, 1996.
7. J. P. Hanna andM. L. Ramundo, "Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children, " Neurology, vol. 50, no. 1, pp. 301-303, 1998.
8. J. W. Baynes and M. H. Dominiczak, Medical Biochemistry, WB Saunders, 4th edition, 2014.
9. P. Ypsilantis, M. Politou, D. Mikroulis et al. , "Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation, " Anesthesia & Analgesia, vol. 105, no. 1, pp. 155-166, 2007.
10. T. G. Short and Y. Young, "Toxicity of intravenous anaesthetics, " Best Practice and Research: Clinical Anaesthesiology, vol. 17, no. 1, pp. 77-89, 2003.
11. A. Wolf, P. Weir, P. Segar, J. Stone, and J. Shield, "Impaired fatty acid oxidation in propofol infusion syndrome, " The Lancet, vol. 357, no. 9256, pp. 606-607, 2001.
12. D. E. Withington, M. K. Decell, and T. Al Ayed, "A case of propofol toxicity: further evidence for a causal mechanism, " Paediatric Anaesthesia, vol. 14, no. 6, pp. 505-508, 2004.
13. A. R. Wolf and F. Potter, "Propofol infusion in children: when does an anesthetic tool become an intensive care liability?" Paediatric Anaesthesia, vol. 14, no. 6, pp. 435-438, 2004.
14. X. Jouven, M.-A. Charles, M. Desnos, and P. Ducimetière, "Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population, " Circulation, vol. 104, no. 7, pp. 756-761, 2001.
15. D. Branca, M. S. Roberti, P. Lorenzin, E. Vincenti, and G. Scutari, "Influence of the anesthetic 2, 6-diisopropylphenol on the oxidative phosphorylation of isolated rat liver mitochondria, " Biochemical Pharmacology, vol. 42, no. 1, pp. 87-90, 1991.
16. K. A. Schenkman and S. Yan, "Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy, " Critical Care Medicine, vol. 28, no. 1, pp. 172-177, 2000.
17. A. V. Vanlander, J. G. Okun, A. de Jaeger et al. , "Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q, " Anesthesiology, vol. 122, no. 2, pp. 343-352, 2015.
18. S. H. Cray, B. H. Robinson, and P. N. Cox, "Lactic acidemia and bradyarrhythmia in a child sedated with propofol, " Critical Care Medicine, vol. 26, no. 12, pp. 2087-2092, 1998.
19. N. Mehta, C. DeMunter, P. Habibi, S. Nadel, and J. Britto, "Shortterm propofol infusions in children, " The Lancet, vol. 354, no. 9181, pp. 866-867, 1999.
20. W. Zhou, H. J. Fontenot, S.-N. Wang, and R. H. Kennedy, "Propofol-induced alterations inmyocardial beta-adrenoceptor binding and responsiveness, " Anesthesia and Analgesia, vol. 89, no. 3, pp. 604-608, 1999.
21. J. A. Myburgh, R. N. Upton, C. Grant, and A. Martinez, "Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model, " Intensive CareMedicine, vol. 27, no. 1, pp. 276-282, 2001.
22. B. Vasile, F. Rasulo, A. Candiani, and N. Latronico, "The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome, " Intensive CareMedicine, vol. 29, no. 9, pp. 1417-1425, 2003.
23. W. Zhou, H. J. Fontenot, S. Liu, andR. H. Kennedy, "Modulation of cardiac calcium channels by propofol, " Anesthesiology, vol. 86, no. 3, pp. 670-675, 1997.
24. W. Jiang, Z.-B. Yang, Q.-H. Zhou, X. Huan, and L. Wang, "Lipid metabolism disturbances and AMPK activation in prolonged propofol-sedated rabbits under mechanical ventilation, " Acta Pharmacologica Sinica, vol. 33, no. 1, pp. 27-33, 2012.
25. M. Savard, N. Dupré, A. F. Turgeon, R. Desbiens, S. Langevin, and D. Brunet, "Propofol-related infusion syndrome heralding a mitochondrial disease: case report, " Neurology, vol. 81, no. 8, pp. 770-771, 2013.
26. A. V. Vanlander, P. G. Jorens, J. Smet et al. , "Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome, " Acta Anaesthesiologica Scandinavica, vol. 56, no. 4, pp. 520-525, 2012.
27. E. B. Stelow, V. P. Johari, S. A. Smith, J. T. Crosson, and F. S. Apple, "Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings, " Clinical Chemistry, vol. 46, no. 4, pp. 577-581, 2000.
28. K. Ahlen, C. J. Buckley, D. B. Goodale, and A. H. Pulsford, "The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care, " European Journal of Anaesthesiology, vol. 23, no. 12, pp. 990-998, 2006.
29. W. S. Hwang, H. M. Gwak, and D. Seo, "Propofol infusion syndrome in refractory status epilepticus, " Journal of Epilepsy Research, vol. 3, no. 1, pp. 21-27, 2013.
30. O. L. Cremer, K. G. M. Moons, E. A. C. Bouman, J. E. Kruijswijk, A. M. G. A. De Smet, and C. J. Kalkman, "Long-term propofol infusion and cardiac failure in adult head-injured patients, " The Lancet, vol. 357, no. 9250, pp. 117-118, 2001.
31. E. B. Stelow, V. P. Johari, S. A. Smith, J. T. Crosson, and F. S. Apple, "Propofol-associated rhabdomyolysis with cardiac involvement in adults: Chemical and anatomic findings, " Clinical Chemistry, vol. 46, no. 4, pp. 577-581, 2000.
32. N. D. Perrier, Y. Baerga-Varela, andM. J. Murray, "Death related to propofol use in an adult patient, " Critical Care Medicine, vol. 28, no. 8, pp. 3071-3074, 2000.
33. A. E. Badr, G. Mychaskiw II, and J. H. Eichhorn, "Metabolic acidosis associated with a new formulation of propofol, " Anesthesiology, vol. 94, no. 3, pp. 536-538, 2001.
34. J. A. Friedman, E. Manno, and J. R. Fulgham, "Propofol, " Journal of Neurosurgery, vol. 96, no. 6, pp. 1161-1162, 2002.
35. D. Ernest and C. French, "Propofol infusion syndrome-report of an adult fatality, " Anaesthesia and Intensive Care, vol. 31, no. 3, pp. 316-319, 2003.
36. B. Casserly, E. O'Mahony, E. G. Timm, S. Haqqie, G. Eisele, and R. Urizar, "Propofol infusion syndrome: an unusual cause of renal failure, " The American Journal of Kidney Diseases, vol. 44, no. 6, pp. e98-e101, 2004.
37. M. A. Kumar, V. C. Urrutia, C. E. Thomas, K. J. Abou-Khaled, and R. J. Schwartzman, "The syndrome of irreversible acidosis after prolonged propofol infusion, " Neurocritical Care, vol. 3, no. 3, pp. 257-259, 2005.
38. A. M. Machata, C. Gonano, T. Brsan, M. Zimpfer, and C. K. Spiss, "Rare but dangerous adverse effects of propofol and thiopental in intensive care, "The Journal of Trauma, vol. 58, no. 3, pp. 643-645, 2005.
39. J. Eriksen and H. M. R. Povey, "A case of suspected nonneurosurgical adult fatal propofol infusion syndrome, " Acta Anaesthesiologica Scandinavica, vol. 50, no. 1, pp. 117-119, 2006.
40. T. M. Merz, B. Regli, H.-U. Rothen, and P. Felleiter, "Propofol infusion syndrome-a fatal case at a low infusion rate, " Anesthesia and Analgesia, vol. 103, no. 4, p. 1050, 2006.
41. S. M. Corbett, J. Moore, J. A. Rebuck, F. B. Rogers, and C. M. Greene, "Survival of propofol infusion syndrome in a headinjured patient, " Critical CareMedicine, vol. 34, no. 9, pp. 2479-2483, 2006.
42. E. L. Zarovnaya, B. C. Jobst, and B. T. Harris, "Propofolassociated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus, " Epilepsia, vol. 48, no. 5, pp. 1002-1006, 2007.
43. J. Orsini, A. Nadkarni, J. Chen, and N. Cohen, "Propofol infusion syndrome: case report and literature review, " The American Journal of Health-System Pharmacy, vol. 66, no. 10, pp. 908-915, 2009.
44. R. Ramaiah, L. Lollo, D. Brannan, and S. Bhananker, "Propofol infusion syndrome in a super morbidly obese patient (BMI = 75), " International Journal of Critical Illness and Injury Science, vol. 1, no. 1, pp. 84-86, 2011.
45. J.-H. Lee, Y.-S. Ko, H.-J. Shin, J.-H. Yi, S.-W. Han, and H.-J. Kim, "Is there a relationship between hyperkalemia and propofol?" Electrolyte and Blood Pressure, vol. 9, no. 1, pp. 27-31, 2011.
46. M. J. Faulkner, M. W. Haley, and L. Littmann, "Propofol infusion syndrome with severe and dynamic brugada electrocardiogram but benign clinical outcome, " Journal of Cardiovascular Electrophysiology, vol. 22, no. 7, pp. 827-828, 2011.
47. T. Annecke, P. Conzen, and L. Ney, "Propofol-related infusion syndrome induced by 'moderate dosage' in a patient with severe head trauma, " Journal of Clinical Anesthesia, vol. 24, no. 1, pp. 51-54, 2012.
48. E. J. Mijzen, B. Jacobs, A. Aslan, and M. G. G. Rodgers, "Propofol infusion syndrome heralded by ECG changes, " Neurocritical Care, vol. 17, no. 2, pp. 260-264, 2012.
49. D. Deters, M. Metzler, M. Morgan, E. Pronovost, and L. Feider, "Propofol infusion syndrome associated with large-dose infusion for treatment of seizure activity, " Dimensions of Critical Care Nursing, vol. 32, no. 3, pp. 118-122, 2013.
50. N. Agrawal, S. Rao, and R. Nair, "A death associated with possible propofol infusion syndrome, " Indian Journal of Surgery, vol. 75, no. 1, pp. 407-408, 2013.
51. N. V. K. C. Pothineni, K. Hayes, A. Deshmukh, and H. Paydak, "Propofol-related infusion syndrome: rare and fatal, " American Journal ofTherapeutics, vol. 22, no. 2, pp. e33-e35, 2015.
52. M. Mayette, J. Gonda, J. L. Hsu, and F. G. Mihm, "Propofol infusion syndrome resuscitation with extracorporeal life support: a case report and review of the literature, " Annals of Intensive Care, vol. 3, no. 1, pp. 1-6, 2013.
53. R. Linko, A. Laukkanen, V. Koljonen, J. Rapola, and T. Varpula, "Severe heart failure and rhabdomyolysis associated with propofol infusion in a burn patient, " Journal of Burn Care & Research, vol. 35, no. 5, pp. e364-e367, 2014.
54. A. Bowdle, P. Richebe, L. Lee, R. Rostomily, and P. Gabikian, "Hypertriglyceridemia, lipemia, and elevated liver enzymes associated with prolonged propofol anesthesia for craniotomy, " Therapeutic Drug Monitoring, vol. 36, no. 5, pp. 556-559, 2014.
55. J. H. Diaz, C. A. Roberts, Oliver J. J, and A. D. Kaye, "Propofol infusion syndrome or not? A case report, " The Ochsner Journal, vol. 14, pp. 434-437, 2014.
56. R. J. Roberts, J. F. Barletta, J. J. Fong et al. , "Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study, " Critical Care, vol. 13, no. 5, article R169, 2009.
57. S. Uezono, Y. U. Hotta, Y. Takakuwa, and M. Ozaki, "Acquired carnitine deficiency: a clinical model for propofol infusion syndrome?" Anesthesiology, vol. 103, p. 909, 2005.
58. M. Savard, N. Dupré, A. F. Turgeon, R. Desbiens, S. Langevin, andD. Brunet, "Propofol-related infusion syndrome heralding a mitochondrial disease: case report, " Neurology, vol. 81, pp. 770-771, 2013.
59. J. Parness, M. Savard, and A. F. Turgeon, "Propofol-related infusion syndrome heralding a mitochondrial disease: case report, " Neurology, vol. 82, no. 5, pp. 461-462, 2014.
60. T. J. Schroeppel, T. C. Fabian, L. P. Clement et al. , "Propofol infusion syndrome: a lethal condition in critically injured patients eliminated by a simple screening protocol, " Injury, vol. 45, no. 1, pp. 245-249, 2014.
61. L. W. Andersen, J. Mackenhauer, J. C. Roberts, K. M. Berg, M. N. Cocchi, and M. W. Donnino, "Etiology and therapeutic approach to elevated lactate levels, "Mayo Clinic Proceedings, vol. 88, no. 10, pp. 1127-1140, 2013.
62. K. Berend, A. P. de Vries, and R. O. Gans, "Physiological approach to assessment of acid-base disturbances, " The New England Journal ofMedicine, vol. 371, no. 15, pp. 1434-1445, 2014.
63. S. M. Forsythe and G. A. Schmidt, "Sodium bicarbonate for the treatment of lactic acidosis, " Chest, vol. 117, no. 1, pp. 260-267, 2000.
64. J.-S. Rachoin, L. S. Weisberg, and C. B. McFadden, "Treatment of lactic acidosis: appropriate confusion, " Journal of Hospital Medicine, vol. 5, no. 4, pp. E1-E7, 2010.
65. J. L. Zimmerman and M. C. Shen, "Rhabdomyolysis, " Chest, vol. 144, no. 3, pp. 1058-1065, 2013.
66. J. Myburgh, D. J. Cooper, S. Finfer et al. , "Saline or albumin for fluid resuscitation in patients with traumatic brain injury, " The New England Journal of Medicine, vol. 357, pp. 874-884, 2007.
67. A. P. Maxwell, K. Linden, S. O'Donnell, P. K. Hamilton, andG. E. McVeigh, "Management of hyperkalaemia, " Journal of the Royal College of Physicians of Edinburgh, vol. 43, no. 3, pp. 246-251, 2013.
68. R. W. Neumar, C. W. Otto, M. S. Link et al. , "Part 8: adult advanced cardiovascular life support: 2010 American Heart AssociationGuidelines forCardiopulmonary Resuscitation and Emergency Cardiovascular Care, " Circulation, vol. 122, no. 3, pp. S729-S767, 2010.
69. H. A. Cooper and J. A. Panza, "Cardiogenic shock, " Cardiology Clinics, vol. 31, no. 4, pp. 567-580, 2013.
70. M. Khan, B. Corbett, and S. Hollenberg, "Mechanical circulatory support in acute cardiogenic shock, " F1000Prime Reports, vol. 6, article 91, 2014.
71. M. S. Roth, A. B. Martin, and J. A. Katz, "Nutritional implications of prolonged propofol use, " American Journal of Health-System Pharmacy, vol. 54, no. 6, pp. 694-695, 1997.